The next FAPESP COVID-19 Webinar, set for July 7th, will discuss the impact of COVID-19 on the human brain, which is much wider than previously thought - COVID-19 syndrome includes neurological symptoms in over 30% of patients.
Entitled "What does COVID-19 have to do with the brain?", the webinar aims to show how understanding SARS-CoV-2's impacts the human brain is key to improve diagnostics, enhance the development of therapeutic agents and, therefore, help patients. The presentations are expected to address the molecular mechanisms of COVID-19 from both cellular and organismal viewpoints,